Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient: case report and review of the literature.

A fatal case of disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell transplant recipient is described. The patient was initially thought to have pulmonary aspergillosis, on the basis of clinical signs and antigenaemia, but Aspergillus was not isolated by culture. Scopulariopsis brevicaulis was subsequently isolated from skin and then from sputum and stool. Further investigation revealed that the infection had spread from a primary pulmonary site to the skin. A review of the literature underscores the difficulty of diagnosing infections caused by such emerging fungal pathogens and the poor outcome of immunocompromised patients with non-Aspergillus mould infections.

[1]  J. Sivik,et al.  Breakthrough invasive fungal infection in an immunocompromised host while on posaconazole prophylaxis: an omission in patient counseling and follow-up , 2008, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[2]  G. Socié,et al.  Breakthrough Rhizopus infection on posaconazole prophylaxis following allogeneic stem cell transplantation , 2008, Bone Marrow Transplantation.

[3]  A. Grigg,et al.  Breakthrough Disseminated Scedosporium prolificans Infection in a Patient with Relapsed Leukaemia on Prolonged Voriconazole Followed by Posaconazole Prophylaxis , 2008, Mycopathologia.

[4]  J. Loeffler,et al.  Contribution of new diagnostic approaches to antifungal treatment plans in high-risk haematology patients. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  C. Lass‐Flörl,et al.  Changing epidemiology of systemic fungal infections. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[6]  J. Kehr,et al.  Cholinergic regulation of vascular endothelial function by human ChAT+ T cells , 2023, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Guarro,et al.  In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis. , 2007, International journal of antimicrobial agents.

[8]  Sayime Aydın,et al.  Treatment of two postoperative endophthalmitis cases due to Aspergillus flavus and Scopulariopsis spp. with local and systemic antifungal therapy , 2007, BMC infectious diseases.

[9]  K. Marr,et al.  Resistant Microascus cirrosus pneumonia can be treated with a combination of surgery, multiple anti-fungal agents and a growth factor , 2006, Mycopathologia.

[10]  M. J. Buitrago,et al.  In Vitro Activities of 10 Combinations of Antifungal Agents against the Multiresistant Pathogen Scopulariopsis brevicaulis , 2006, Antimicrobial Agents and Chemotherapy.

[11]  H. Rutenberg,et al.  Fungal prosthetic mitral valve endocarditis caused by Scopulariopsis species: case report and review of the literature. , 2006, The Journal of thoracic and cardiovascular surgery.

[12]  S. Suh,et al.  [Infection with Scopulariopsis brevicaulis after Cosmetic Surgery of the Face.]. , 2006, The Korean journal of laboratory medicine.

[13]  G. Verleden,et al.  Fatal Scopulariopsis infection in a lung transplant recipient: a case report. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  W. Kern,et al.  Breakthrough Invasive Infection Due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a Stem Cell Transplant Patient Receiving Liposomal Amphotericin B and Caspofungin for Suspected Aspergillosis , 2005, Infection.

[15]  K. Marr,et al.  Emerging fungal diseases. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  Nina Singh,et al.  Reactivity of Platelia Aspergillus Galactomannan Antigen with Piperacillin-Tazobactam: Clinical Implications Based on Achievable Concentrations in Serum , 2004, Antimicrobial Agents and Chemotherapy.

[17]  M. A. Malecha Fungal Keratitis Caused by Scopulariopsis brevicaulis Treated Successfully With Natamycin , 2004, Cornea.

[18]  J. Perfect,et al.  Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients. , 2004, The Journal of infection.

[19]  O. Agbede,et al.  Scopulariopsis associated meningitis in adult Nigerian AIDS patient--a case report. , 2004, West African journal of medicine.

[20]  L. Argaud,et al.  Fatal Microascus trigonosporus (Anamorph Scopulariopsis) Pneumonia in a Bone Marrow Transplant Recipient , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[21]  T. Scarabelli,et al.  Fungal endocarditis due to Scopulariopsis. , 2003, Annals of internal medicine.

[22]  K. Ng,et al.  Scopulariopsis brevicaulis infection in a patient with acute myeloid leukemia. , 2003, The Medical journal of Malaysia.

[23]  M. J. Buitrago,et al.  Scopulariopsis brevicaulis, a Fungal Pathogen Resistant to Broad-Spectrum Antifungal Agents , 2003, Antimicrobial Agents and Chemotherapy.

[24]  M. Ghannoum,et al.  Human Hyalohyphomycoses: A Review of Human Infections Due to Acremonium spp., Paecilomyces spp., Penicillium spp., and Scopulariopsis spp. , 2003, Journal of chemotherapy.

[25]  L. Misery,et al.  [Subcutaneous mycosis due to Scopulariopsis brevicaulis in an aplasic patient]. , 2003, Annales de dermatologie et de vénéréologie.

[26]  Y. Sohara,et al.  Scopulariopsis fungus ball. , 2002, The Annals of thoracic surgery.

[27]  W. Coulson,et al.  Deep‐seated mycosis as a complication in bone marrow transplantation patients
 , 2002, Mycoses.

[28]  B. Lebeau,et al.  [Subcutaneous mycosis due to Scopulariopsis brevicaulis in an immunocompromised patient]. , 2001, Annales de dermatologie et de venereologie.

[29]  D. Vittecoq,et al.  Recurrent subcutaneous infection due to Scopulariopsis brevicaulis in a liver transplant recipient. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  B. Piraccini,et al.  Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. , 2000, Journal of the American Academy of Dermatology.

[31]  J. Baddley,et al.  Microascus cinereus (Anamorph scopulariopsis) brain abscess in a bone marrow transplant recipient. , 2000, Journal of clinical microbiology.

[32]  Ryder Ns,et al.  Activity of terbinafine against serious fungal pathogens , 1999, Mycoses.

[33]  J. Guarro,et al.  In Vitro Antifungal Susceptibilities ofScopulariopsis Isolates , 1999, Antimicrobial Agents and Chemotherapy.

[34]  Elizabeth M. Johnson,et al.  In Vitro Activity of Syn-2869, a Novel Triazole Agent, against Emerging and Less Common Mold Pathogens , 1999, Antimicrobial Agents and Chemotherapy.

[35]  J. Latgé,et al.  Molecular diagnosis and epidemiology of fungal infections. , 1998, Medical mycology.

[36]  R. E. Kalina,et al.  Posttraumatic fungal endophthalmitis resulting from Scopulariopsis brevicaulis. , 1997, Retina.

[37]  B. Piraccini,et al.  Onychomycosis due to Scopulariopsis brevicaulis: clinical features and response to systemic antifungals , 1996, The British journal of dermatology.

[38]  M. Pereiro,et al.  Plantar infection by Scopulariopsis brevicaulis. , 1996, Dermatology.

[39]  R. Migrino,et al.  Deep tissue infections caused by Scopulariopsis brevicaulis: report of a case of prosthetic valve endocarditis and review. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  M. Mustafa,et al.  Disseminated Microascus cirrosus infection in pediatric bone marrow transplant recipient , 1995, Journal of clinical microbiology.

[41]  L. Gentry,et al.  Scopulariopsis endocarditis associated with Duran ring valvuloplasty. , 1995, Texas Heart Institute journal.

[42]  P. Umbert,et al.  Ulcerous granulomatous cheilitis with lymphatic invasion caused by Scopulariopsis brevicaulis infection. , 1994, Journal of the American Academy of Dermatology.

[43]  A. Lotery,et al.  Fungal keratitis caused by Scopulariopsis brevicaulis: successful treatment with topical amphotericin B and chloramphenicol without the need for surgical debridement. , 1994, The British journal of ophthalmology.

[44]  N. Cox,et al.  Cutaneous ‘ringworm’ lesions of Scopulariopsis brevicaulis , 1993, The British journal of dermatology.

[45]  J. Dhar,et al.  Scopulariopsis brevicaulis skin lesions in an AIDS patient. , 1993, AIDS.

[46]  J. Neglia,et al.  Invasive Scopulariopsis in the immunocompromised host. , 1987, The American journal of medicine.

[47]  L. Wheat,et al.  Opportunistic Scopulariopsis pneumonia in an immunocompromised host. , 1984, Southern medical journal.